How Is The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Expected To Grow At 6.4% CAGR Over 2025–2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In The Coming Years?
The market size of bioinformatics in in-vitro diagnostics (ivd) testing has seen a significant increase in the past years. The projection is that it will escalate from $93.02 billion in 2024 to $98.89 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. The growth experienced in the historical period is credited to factors such as the enhancement of healthcare infrastructure, expansion of biobanks, a surge in the elderly population, governmental initiatives and funding, along with the growth in personalized medicine.
The market size of bioinformatics in in-vitro diagnostics (ivd) testing is set to witness robust growth in the upcoming years, with predictions suggesting it will ascend to $126.76 billion by 2029 with a compound annual growth rate (CAGR) of 6.4%. This escalating growth over the forecast period is attributed to various factors including the increasing incidence of diseases, incorporation of IT in the healthcare sector, governmental support, a shift towards precision medicine, increasing consciousness about bioinformatics’ advantages in diagnostics amongst healthcare professionals, and a reduction in the cost of genomic sequencing. The forecast period is expected to see major trends such as artificial intelligence (AI) and machine learning, next-generation sequencing, point-of-care (POC) testing, cloud computing coupled with big data, and developments in immunochemical techniques.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16629&type=smp
What Drivers Are Accelerating Expansion Of The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?
The growth of the bioinformatics in IVD testing market is anticipated to surge owing to the rising prevalence of cancer. Cancer is a generic term encompassing a myriad of diseases marked by unusual cell growth capable of invading and diffusing to various other body components. Factors such as exposure, lifestyle choices, and environmental factors primarily contribute to the escalating instances of Cancer. The advent of bioinformatics in IVD testing revolutionizes cancer diagnosis by delivering precise, individualized, and broad genetic revelations, thereby promoting early detection, informed treatment selection, and improved patient prognoses. For example, the National Association of Chronic Disease Directors (NACDD), a US government agency, reported in 2022 that approximately 40% of American adults contend with multiple chronic conditions (MCC). There’s a mounting body of evidence suggesting that the presence of one chronic ailment elevates the chances of contracting more, particularly with advancing age. These rising instances of Cancer hence catalyze the bioinformatics in the IVD testing market.
How Is The Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Broken Down By Segment?
The bioinformatics in in-vitro diagnostics (ivd) testingmarket covered in this report is segmented –
1) By Type: Hardware; Software
2) By Type Of Test: Blood Based Tests; Tissue Based Tests
3) By Application: Cardiovascular Diseases; Chronic Diseases; Diabetes; Cancer; Other Applications
Subsegments:
1) By Hardware: Analyzers; Laboratory Equipment; Data Storage Devices; Sensors And Detectors; Workstations And Data Processing Hardware
2) By Software: Bioinformatics Platforms; Data Management and Integration Software; Analytics And Interpretation Software; Cloud-Based Software Solutions; AI-Based Software For Diagnostics
Which Market Trends Are Expected To Define The Future Of The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?
Major firms in the bioinformatics space of the IVD testing market are shifting their focus towards the creation of innovative solutions like next-generation sequencing (NGS) technology. This technology has the potential to enhance the ability to detect and analyse genetic mutations, increase the precision of diagnostics, and aid in the implementation of personalized medicine. Next-generation sequencing is a highly efficient technology that enables the quick sequencing of complete genomes or specified DNA and RNA regions, paving the way for extensive genetic investigations. For instance, Illumina Inc., a major player in the biotechnological space based in the US, unveiled a new pan-cancer companion diagnostic indication for its CE-marked TruSight Oncology Comprehensive (EU) test, in May 2022. This advanced test can identify cancer sufferers with solid tumors exhibiting NTRK gene fusions, primarily NTRK1, NTRK2, or NTRK3, who may potentially benefit from the use of targeted therapy with Bayer’s drug Vitrakvi. The TruSight Oncology Comprehensive (EU) test is a comprehensive genomic profiling assay that employs next-generation sequencing to analyze numerous tumor genes and biomarkers from a single biopsy sample to ascertain a patient’s unique cancer genomic makeup.
Which Firms Are Making The Biggest Impact In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?
Major companies operating in the bioinformatics in in-vitro diagnostics (IVD) testing market are Siemens Healthineers, International Business Machines Corporation, Medtronic Inc., Parker Hannifin Corp., Illumina Inc, PerkinElmer Inc., QIAGEN N.V., Kollmorgen Corp, Bioreference Laboratories Inc., AssureRx Health Inc., Biodesix Inc., Crescendo Bioscience Inc., Affymetrix, Complete Genomics Inc., Aperico Technologies Inc., One Lambda Inc., Datech Oncology, Life Technologies, Signal genetics, CardioDx Inc.
Access The Complete Report Here:
Which Geographic Regions Are Creating Strong Demand In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?
North America was the largest region in the bioinformatics in in-vitro diagnostics (IVD) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioinformatics in in-vitro diagnostics (IVD) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=16629&type=smp
Browse Through More Reports Similar to the Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market 2025, By The Business Research Company
In Vitro Diagnostics Ivd Quality Control Global Market Report 2025
In Vitro Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
Bioinformatics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
